Provided by Tiger Trade Technology Pte. Ltd.

Corgi Beauty, Skincare & Aesthetics ETF

27.75
-0.3509-1.25%
Volume:36
Turnover:1K
Market Cap:971.12K
PE:- -
High:27.75
Open:28.10
Low:27.75
Close:28.10
52wk High:29.89
52wk Low:24.32
Shares:35.00K
Float Shares:35.00K
Volume Ratio:0.00
T/O Rate:0.10%
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Analysts Have Conflicting Sentiments on These Healthcare Companies: Hims & Hers Health (HIMS) and Oxford BioMedica (OtherOXBDF)

TIPRANKS
·
Sep 02

Accc - Without Divestiture of Carefree & Stayfree Brands, Acquisition to Substantially Lessen Competition in Period Care Products' Supply in Australia

THOMSON REUTERS
·
Sep 02

Australia's Accc - Kimberly-Clark’s Acquisition of Kenvue Approved Subject to Sale of Carefree and Stayfree Brands

THOMSON REUTERS
·
Sep 02

Estee Lauder Cos. Cl a Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Sep 02

AbbVie Inc. Stock Underperforms Tuesday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Sep 02

Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements

Reuters
·
Sep 01

NetraMark Appoints Abivax Regulatory Chief Keith Fournier to Board

Reuters
·
Sep 01

Align Technology Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 01

Align Technology Director Quentin S. Blackford Files Initial Beneficial Ownership Statement (Form 3)

Reuters
·
Sep 01

Estée Lauder EVP, General Counsel Rashida La Lande Disposes of 14,357 Common Shares Worth $1.51 Million

Reuters
·
Sep 01

Quentin Blackford to Join Align Technology Board of Directors

THOMSON REUTERS
·
Sep 01

Align Technology Appoints iRhythm CEO Quentin Blackford to Board

Reuters
·
Sep 01

Hims & Hers Health Enters Australia, Marks First Asia-Pacific Market Presence

Reuters
·
Sep 01

Hims & Hers Enters Australia in First Asia-Pacific Expansion

Reuters
·
Sep 01

Hims & Hers Offers GLP-1 Weight-Loss Drugs, Men's Health Treatments in Australia

Reuters
·
Sep 01

States Namenda Tablets not Withdrawn for Safety or Effectiveness Reasons - Federal Register

THOMSON REUTERS
·
Aug 31

FDA: Will not Begin Procedures to Withdraw Approval of Abbreviated New Drug Applications That Refer to Namenda Products - Federal Register

THOMSON REUTERS
·
Aug 31

AbbVie to Present at Wells Fargo Healthcare Conference

Reuters
·
Aug 31

CICC Upgrades Estee Lauder Companies to Outperform From Neutral, Adjusts PT to $122 From $65

MT Newswires Live
·
Aug 31

Estee Lauder upgraded to Outperform from Market Perform at CICC

TIPRANKS
·
Aug 30